Skip to content
Peptigraph home

Tirzepatide 15 mg Vial: Reconstitution and Dosing Chart

How much bacteriostatic water to add to a 15 mg vial of Tirzepatide, the concentration you get, and a full dose-to-units chart.

Medically reviewed by Juan Pablo Frías, MD · · DisclosureGLP-1 / GIP dual agonistUpdated
Vial size
15 mg
With 2 mL water
7.5 mg/mL
common choice
10 units contain
0.75 mg
at 2 mL, U-100
Whole vial
200 units
2 mL on a U-100 scale

How much water to add

Bacteriostatic water only changes the concentration, not the amount of Tirzepatide in the vial. More water means more units per dose (easier to read), less water means fewer.

Tirzepatide 15 mg vial: concentration by water added
Water addedConcentration10 units contain1 mg isWhole vial
1 mL15 mg/mL1.5 mg6.7 u100 u
2 mL7.5 mg/mL0.75 mg13.3 u200 u
2.5 mL6 mg/mL0.6 mg16.7 u250 u
3 mL5 mg/mL0.5 mg20 u300 u

Calculator and full dosing table

Preset to the 15 mg vial. Change any value; the table below the result updates with it.

1Vial size
2Bacteriostatic water added
3Dose per injection
4Syringe (U-100)
Draw to
66.67units
= 0.67 mL on a 1 mL U-100 insulin syringe
15 mg vial2 mL water5 mg dose
Concentration
7.5 mg/mL
Doses per vial
3
Weeks (1 dose/wk)
3
Math only. It does not recommend a dose.

66.67 units (0.67 mL) on a 1 mL U-100 syringe: 5 mg from a 15 mg vial + 2 mL water (Tirzepatide).

Dosing table for a 15 mg vial

Syringe units (U-100) for each dose, by how much bacteriostatic water you add.

Tirzepatide: U-100 syringe units per dose for a 15 mg vial
Dose1 mL water2 mL water2.5 mL water3 mL water
1 mg6.6713.3316.6720
2.5 mg16.6733.3341.6750
5 mg33.3366.6783.33100
7.5 mg50100125150
10 mg66.67133.33166.67200
12.5 mg83.33166.67208.33250
15 mg100200250300

How the math works

Concentration is the vial's milligrams divided by the water you add. Volume to draw is your dose divided by that concentration. On a U-100 syringe, 1 mL is 100 units, so units = mL × 100.

15 mg ÷ 2 mL = 7.5 mg/mL
5 mg ÷ 7.5 mg/mL = 0.67 mL
0.67 mL × 100 = 66.67 units
66.67 units · 0.67 mL · 5 mg from 15 mg + 2 mL
Math only. The amounts in these tables are reference values for the arithmetic, not dose recommendations.

Sourced doses for a 15 mg tirzepatide vial

People with obesity and type 2 diabetes got once-weekly tirzepatide at 10 mg or 15 mg for 72 weeks in that trial.[3]

How far a 15 mg vial goes

Dose table for a 15 mg tirzepatide vial; water 1 / 2 / 3 mL gives 15 / 7.5 / 5 mg/mL. Row format for the 15 mg tirzepatide vial: dose, doses per vial, units at 1 / 2 / 3 mL. 2.5 mg: 6 weekly doses, no remainder; 16.67 / 33.33 / 50 units. 5 mg: 3 weekly doses, no remainder; 33.33 / 66.67 / 100 units. 10 mg: 1 weekly dose, 5 mg left; 66.67 / 133.33‡ / 200‡ units. 15 mg: 1 weekly dose, no remainder; 100 / 200‡ / 300‡ units. († marks a 15 mg tirzepatide reading under 5 units, hard to measure accurately; ‡ marks one over the 100 units a 1 mL U-100 syringe holds.)

Calculated from vial mg 15; water mL 1, 2, 3; units per mL 100; doses mg 2.5, 5, 10, 15; rows dose mg 2.5, doses 6, remainder mg 0, units 16.667, 33.333, 50; dose mg 5, doses 3, remainder mg 0, units 33.333, 66.667, 100; dose mg 10, doses 1, remainder mg 5, units 66.667, 133.333, 200; dose mg 15, doses 1, remainder mg 0, units 100, 200, 300. Formula: doses = floor(vialMg / doseMg); units = doseMg x waterMl / vialMg x 100

Measuring check for the 15 mg vial: 1 mL (15 mg/mL) spans 16.67 to 100 units, all within 5 to 100; 2 mL (7.5 mg/mL) spans 33.33 to 200 units, some over 100 units; 3 mL (5 mg/mL) spans 50 to 300 units, some over 100 units. For tirzepatide at 15 mg, every sourced dose is readable between 5 and 100 units at 1 mL.

Calculated from vial mg 15; doses mg 2.5, 5, 10, 15; readable range units 5, 100. Formula: units = doseMg x waterMl / vialMg x 100, checked against 5 and 100

Label check for 15 mg

A 15 mg/0.5 mL single-dose product is on the label, as a one-injection pen or vial.[4]

The labelled 15 mg/0.5 mL product is 30 mg/mL, so the full 15 mg sits in a 50-unit volume.

Calculated from dose mg 15; volume mL 0.5; units per mL 100. Formula: 15 / 0.5 = 30 mg/mL; 0.5 x 100 = 50 units

No multi-dose Zepbound vial is 15 mg in total; 15 mg/0.6 mL is the dose that the 60 mg multi-dose vial divides into.[4]

What 15 mg vials were listed at

Checked on 2026-10-02, 18 listings of a 15 mg research vial had a median price of $125.00 ($8.33 per mg), with the cheapest at $59.00 and the dearest at $225.00.

Calculated from source our price listings dataset; vial mg 15; listings 18; median 125; min 59; max 225; checked 2026-10-02. Formula: median / vialMg = 125.0 / 15 = 8.33 per mg

Common questions

How much water goes in a 15 mg vial of Tirzepatide?

That choice only changes the concentration. With 2 mL, a 15 mg vial is 7.5 mg/mL; with 1 mL it is 15 mg/mL. Less water means fewer units per dose and harder-to-read marks for small doses.

How many units is 1 mg from a 15 mg vial?

With 2 mL of water, 1 mg is 13.3 units on a U-100 syringe. With other water amounts, see the table.

How many doses are in a 15 mg vial?

Divide the vial size by the dose (in the same unit). The calculator on this page shows the number of whole doses for any dose you pick.

How much water goes in a 15mg tirzepatide vial?

For this 15 mg tirzepatide vial, 1 mL gives 15 mg/mL, 2 mL gives 7.5 and 3 mL gives 5; one U-100 unit then holds 0.15, 0.075 or 0.05 mg.

Calculated from vial mg 15; water mL 1, 2, 3; units per mL 100. Formula: mg/mL = 15 / mL; mg per unit = (mg/mL) / 100

What dose do 15 mg tirzepatide searches refer to?

On the Zepbound label, 15 mg is the maximum dosage for all indications, injected once weekly.[4]

More on Tirzepatide

Sources

  1. 1Metric (SI) Prefixes (NIST Reference on Constants, Units, and Uncertainty)National Institute of Standards and Technology (NIST) · 2025physics.nist.govAccessed 2 Oct 2026
  2. 2BASAGLAR (insulin glargine) injection, prescribing information (DailyMed)U.S. Food and Drug Administration / DailyMed (Eli Lilly and Company label) · 2026dailymed.nlm.nih.govAccessed 2 Oct 2026
  3. 3Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial.Lancet (London, England) · 2023PMID 37385275Accessed 2 Oct 2026
  4. 4ZEPBOUND prescribing information (FDA label)FDA label, DailyMed · current labeldailymed.nlm.nih.govAccessed 2 Oct 2026

Found an error? Report a correction.